Arkolith/Insider Trading/SLXN/Form 4

Shirvan Mitchell

CSO and CDOSilexion Therapeutics Corp (SLXN) · full profile →Form 4 · filed Mar 30, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$31K
Net Open-Market Flow
-$31K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 26, 2026Sell(S)23K$1.36$31K28K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001178913-26-001858) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML